{
  "trial_id": "NCT01152580",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, menopausal status, baseline bone density, baseline serum osteocalcin levels, baseline serum type-1 collagen cross-linked N-telopeptide (NTX) levels, baseline quality of life scores, baseline sleep quality scores, alcohol consumption habits, medication use, presence of comorbid conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment",
        "Body Mass Index (BMI)"
      ],
      "remaining_candidate_features": [
        "menopausal status",
        "baseline bone density",
        "baseline serum osteocalcin levels",
        "baseline serum type-1 collagen cross-linked N-telopeptide (NTX) levels",
        "baseline quality of life scores",
        "baseline sleep quality scores",
        "alcohol consumption habits",
        "medication use",
        "presence of comorbid conditions"
      ]
    },
    "processed-gen-response": "Age, sex, menopausal status, baseline bone density, baseline serum osteocalcin levels, baseline serum type-1 collagen cross-linked N-telopeptide (NTX) levels, baseline quality of life scores, baseline sleep quality scores, alcohol consumption habits, medication use, presence of comorbid conditions."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Baseline Bone Density, Baseline Serum Osteocalcin Levels, Baseline Serum Type-1 Collagen Cross-linked N-telopeptide (NTX) Levels, Menopausal Status, Quality of Life, Sleep Quality,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male"
      ],
      "remaining_candidate_features": [
        "Baseline Bone Density",
        "Baseline Serum Osteocalcin Levels",
        "Baseline Serum Type-1 Collagen Cross-linked N-telopeptide (NTX) Levels",
        "Menopausal Status",
        "Quality of Life",
        "Sleep Quality"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Body Mass Index, Baseline Bone Density, Baseline Serum Osteocalcin Levels, Baseline Serum Type-1 Collagen Cross-linked N-telopeptide (NTX) Levels, Menopausal Status, Quality of Life, Sleep Quality"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Menopausal Status, Region of Enrollment, Body Mass Index, History of Osteoporosis, History of Osteopenia, History of Fractures, Sleep Quality, Menopausal Quality of Life.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index (BMI)",
          "Body Mass Index"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Menopausal Status",
        "History of Osteoporosis",
        "History of Osteopenia",
        "History of Fractures",
        "Sleep Quality",
        "Menopausal Quality of Life"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Menopausal Status, Region of Enrollment, Body Mass Index, History of Osteoporosis, History of Osteopenia, History of Fractures, Sleep Quality, Menopausal Quality of Life."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, ethnicity, body mass index (BMI), menopausal status, years since menopause, history of osteoporosis or osteopenia, history of fractures, family history of osteoporosis, smoking status, alcohol consumption, physical activity level, calcium and vitamin D supplementation, medical history (e.g., hyperparathyroidism, metastatic bone disease, multiple myeloma, chronic steroid use), medication use (e.g., osteoporotic drugs, hypnotics, CYP1A2 inhibiting drugs, fluvoxamine), sleep quality, quality of life, bone turnover markers at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "Body Mass Index (BMI)",
          "body mass index (BMI)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "race",
        "menopausal status",
        "years since menopause",
        "history of osteoporosis or osteopenia",
        "history of fractures",
        "family history of osteoporosis",
        "smoking status",
        "alcohol consumption",
        "physical activity level",
        "calcium and vitamin D supplementation",
        "medical history (e.g., hyperparathyroidism, metastatic bone disease, multiple myeloma, chronic steroid use)",
        "medication use (e.g., osteoporotic drugs, hypnotics, CYP1A2 inhibiting drugs, fluvoxamine)",
        "sleep quality",
        "quality of life",
        "bone turnover markers at baseline"
      ]
    },
    "processed-gen-response": "age, sex, race, ethnicity, body mass index (BMI), menopausal status, years since menopause, history of osteoporosis or osteopenia, history of fractures, family history of osteoporosis, smoking status, alcohol consumption, physical activity level, calcium and vitamin D supplementation, medical history (e.g., hyperparathyroidism, metastatic bone disease, multiple myeloma, chronic steroid use), medication use (e.g., osteoporotic drugs, hypnotics, CYP1A2 inhibiting drugs, fluvoxamine), sleep quality, quality of life, bone turnover markers at baseline."
  }
}